| Sign In to gain access to subscriptions and/or personal tools. |
Modulation of Gingival Fibroblast Minocycline Accumulation by Biological MediatorsSection of Periodontology, College of Dentistry, The Ohio State University Health Sciences Center, 305 West 12th Avenue, PO Box 182357, Columbus, OH 43218-2357, USA; Correspondence: * walters.2{at}osu.edu
Gingival fibroblasts actively accumulate tetracyclines, thereby enhancing their redistribution from blood to gingiva. Since growth factors and pro-inflammatory cytokines regulate many fibroblast activities, they could potentially enhance fibroblast minocycline accumulation. To test this hypothesis, we treated gingival fibroblast monolayers for 1 or 6 hours with platelet-derived growth factor-BB (PDGF), fibroblast growth factor-2 (FGF), transforming growth factor-β1 (TGF), or tumor necrosis factor-  (TNF). Minocycline uptake was assayed at 37° by a fluorescence method. All 4 factors significantly enhanced minocycline uptake (P  0.008, ANOVA), primarily by increasing the affinity of transport. Treatment for 6 hours with 10 ng/mL FGF, PDGF, TGF, or TNF enhanced fibroblast minocycline uptake by 19% to 25%. Phorbol myristate acetate enhanced fibroblast minocycline uptake by 28%, suggesting that protein kinase C plays a role in up-regulating transport. These effects on transport provide a mechanism by which systemic tetracyclines could be preferentially distributed to gingival wound or inflammatory sites.
Key Words: tetracyclines • antimicrobial chemotherapy • aggressive periodontitis • matrix metalloproteinases
Aggressive forms of periodontitis are difficult to treat by conventional scaling and root planing alone, because some of the associated bacterial pathogens (e.g., Actinobacillus actinomycetemcomitans) are capable of invading epithelial cells lining the pocket or gingival crevice (Christersson et al., 1987; Fives-Taylor et al., 1996). For this reason, tetracycline antibiotics are frequently used as adjuncts in the treatment of aggressive periodontitis. Tetracyclines can penetrate epithelial cells and are capable of inhibiting A. actinomycetemcomitans (Pavicic et al., 1992; van Winkelhoff et al., 1996). Interestingly, they appear to distribute preferentially to gingival crevicular fluid (GCF). When taken by the systemic route, tetracyclines attain GCF levels that are approximately 4- to 5-fold higher than serum levels (Ciancio et al., 1980; Pascale et al., 1986). Our recent work has shown that gingival fibroblasts express transporters that allow them to take up extracellular tetracyclines and sequester them in the gingiva (Yang et al., 2002). Although the affinity of transport is relatively low, fibroblasts accumulate remarkable amounts of these agents. For minocycline, the observed cellular/extracellular concentration (C/E) ratios were > 60. These findings suggest that gingival fibroblasts can function as reservoirs for tetracyclines. Their ability to accumulate high levels of these agents may enhance redistribution of tetracyclines from the bloodstream to the gingiva and sustain their therapeutic levels in GCF.
In the periodontium, PDGF, FGF-2, and TGF-β1 serve as important biological mediators for wound healing and regeneration (Cochran and Wozney, 1999), while TNF-
Isolation and Culture of Gingival Fibroblasts Fibroblasts were isolated from an explant obtained from a healthy (firm, non-edematous, non-bleeding, pink) interproximal papilla of a 36-year-old male as previously described (Mariotti and Cochran, 1990), according to an IRB-approved informed consent procedure. Cells were cultured at 37°C in 5% CO2 in minimal essential medium (MEM, Life Technologies Inc., Rockville, MD, USA) supplemented with 2 mM glutamine and 10% heat-inactivated fetal bovine serum. For the experiments described below, 3.2 x 104 fibroblasts were seeded into each well of a 24-well cell culture plate. The cells were fed 3 days later and formed a confluent monolayer (as assessed by microscopy) within 6 days. Individual experiments were designed to have triplicate wells of each experimental condition. To enhance fibroblast responsiveness to growth factors and cytokines, confluent cells were starved for 20 hrs in MEM containing 0.5% fetal bovine serum prior to treatment with these mediators. Fibroblasts were used between passage numbers 4 and 15.
Conditions for fibroblast treatment with medium alone (control), PDGF-BB, FGF-2 (basic FGF), TGF-β1, TNF-
Assay of Minocycline Transport Transport was assayed by the measurement of cell-associated minocycline fluorescence. Multiwell culture plates containing confluent cell monolayers were washed 4 times with Hanks’ balanced salts solution (HBSS), overlaid with 0.2 mL/well HBSS, and warmed to 37°C prior to assay. The assay was initiated by the addition of 0.2 mL of warm HBSS containing twice the desired final minocycline concentration to each well, by means of multichannel pipettes. After incubation at 37°C for 3 min, the minocycline solutions were quickly removed. Each well was rapidly washed 4 times with HBSS to eliminate extracellular antibiotics, according to the method described by Gazzola et al.(1981). Cell monolayers underwent lysis in 1 mL of water. The lysate was centrifuged at 13,000 x g for 6 min and mixed with an equal volume of ethylene glycol containing 200 mM citric acid and 200 mM magnesium acetate. Fluorescence of the mixture was measured as previously described (Lever, 1972). Antibiotic content was normalized to cell protein by the method of Bradford (1976). The rate of fibroblast minocycline transport is constant for approximately 3 minutes after cell exposure to the antibiotic in vitro. To determine the affinity and velocity of transport, we measured the kinetics of transport during this linear initial phase and analyzed it by the Lineweaver-Burk method. We used EnzPack for Windows (Biosoft, Ferguson, MO, USA) to derive the Michaelis constant (Km) and maximum transport velocity (Vmax) values from regression lines obtained with the data.
At relatively low concentrations (0.3 to 10 ng/mL), FGF-2 and PDGF induced a significant dose-dependent enhancement of gingival fibroblast minocycline uptake compared with untreated controls (P 0.003, repeated-measures ANOVA, Fig. 1 ). FGF-2 (10 ng/mL) enhanced minocycline uptake by 20% after 1 hr of treatment and by 26% after 6 hrs. PDGF (10 ng/mL) produced 31% enhancement after 1 hr and 23% enhancement after 6 hrs.
TGF-β (1 to 30 ng/mL, 6 hrs) enhanced minocycline accumulation in a dose-dependent manner (P < 0.001, ANOVA, Fig. 2 ), but produced no significant effect after 1 hr of treatment (P = 0.24, ANOVA). Treatment for 6 hrs with 10 ng/mL TGF-β enhanced minocycline accumulation by 21%. TNF- (1 to 30 ng/mL) enhanced minocycline accumulation within 1 hr (P < 0.001, ANOVA), and the effect was sustained through 6 hrs of treatment (P = 0.008). Treatment with 10 ng/mL TNF- enhanced minocycline accumulation by 15% at 1 hr and by 19% at 6 hrs (Fig. 2).
Phorbol esters activate protein kinase C (PKC) in a receptor-independent manner. To determine whether PKC could be involved in signaling for enhanced minocycline uptake, we examined the effects of phorbol myristate acetate (PMA, 3 to 100 nM) on the accumulation of several different tetracyclines by fibroblasts. Brief treatment with PMA significantly enhanced fibroblast uptake of minocycline, doxycycline, and tetracycline (P 0.002, ANOVA, Fig. 3). Stimulation by 100 nM PMA enhanced minocycline transport by 28%. Under identical conditions, doxycycline transport increased by 45%, and tetracycline transport increased by 90%.
The mechanism of enhancement by growth factors, pro-inflammatory cytokines, and PMA was investigated by kinetic analysis. Untreated control fibroblasts transported minocycline with a Km of 108 µg/mL at a Vmax of 15.2 ng/min/µg cell protein (Table  ). Treatment with FGF-2, PDGF, TGF-β, TNF-, and interleukin-1β (IL-1β) all significantly decreased the Km (and increased the affinity) of minocycline transport (P < 0.05, Dunnett’s test). In addition, activation with PMA significantly decreased the Km of transport. None of these factors significantly enhanced the maximum velocity of transport, but TGF-β slowed the velocity of transport significantly (P < 0.05, Dunnett’s test).
Tetracyclines are one of the most widely used classes of antibiotics in periodontics. In addition to their antimicrobial effects, tetracyclines inhibit matrix metalloproteinases (MMPs), which play a role in connective tissue destruction. Through this anti-inflammatory mechanism, low-dose doxycycline therapy enhances the therapeutic response to scaling and root planing (reviewed by Oringer, 2002). The focus of the present work was to determine whether biological mediators associated with wound healing and inflammation could potentially alter the distribution of systemic tetracyclines to the gingiva. Gingival fibroblasts possess a transport system that allows them to take up tetracyclines and act as reservoirs for these agents. The transporter exhibits characteristics similar to those of the widely distributed organic cation transporter family, and can move tetracyclines in the forward or reverse direction to maintain equilibrium between intracellular and extracellular concentrations (Yang et al., 2002). Forward transport into fibroblasts presumably occurs when tetracycline levels are increasing or peaking in the tissue. As antibiotic levels in the blood and tissue decrease from their peak values, the direction of transport reverses in a manner that could maintain relatively high antimicrobial levels in interstitial fluid and GCF (Yang et al., 2002). This could explain why tetracycline, doxycycline, and minocycline levels are higher in GCF than in blood when sampled after blood levels have receded from their peak values (Ciancio et al., 1980; Gordon et al., 1981; Pascale et al., 1986).
Periodontal inflammation, wound healing, and regeneration are coordinated by a multitude of inflammatory mediators and growth factors released by resident cells, platelets, and infiltrating leukocytes. Among the most important are PDGF (a potent fibroblast mitogen), FGF-2 (which stimulates angiogenesis and fibroblast proliferation), TGF-β (which stimulates fibroblast matrix protein synthesis), and TNF-
With its ability to activate PKC directly, phorbol myristate acetate (PMA) is a useful tool for evaluating the role of this signaling pathway in cell regulation. PMA rapidly enhances fibroblast transport of minocycline, doxycycline, and tetracycline, suggesting that PKC is involved in signaling for increased transport activity. The mechanism of enhancement (increased transporter affinity) and the magnitude of the enhancement are similar to those produced by PDGF, FGF-2, TGF-β, and TNF-
As illustrated in Fig. 3
The authors are grateful to Dr. Angelo Mariotti for providing human gingival fibroblasts. This investigation was supported by USPHS research grant DE12601 from the National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD 20892. Received for publication January 8, 2004. Revision received December 6, 2004. Accepted for publication January 12, 2005.
Journal of Dental Research, Vol. 84, No. 4,
320-323 (2005) This article has been cited by other articles:
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
|
|
 |
|
Sign In to gain access to subscriptions and/or personal tools.
TOP
ABSTRACT
INTRODUCTION
